ACAD
31.54
-1.96
-5.85%
AEMD
5.81
-0.33
-5.37%
APRI
0.419
-0.051
-10.851%
ARNA
1.81
-0.1
-5.24%
ATEC
0.31
+0.03
+9.62%
CNAT
1.967
-0.163
-7.6338%
CRXM
0.17
+0.02
+11.96%
CYTX
2.01
+0.01
+0.50%
DXCM
77.67
+0.08
+0.10%
GNMK
8.36
-0.61
-6.80%
HALO
8.56
-0.63
-6.86%
ILMN
138.86
-7.73
-5.2731%
INNV
0.23
+0.01
+2.61%
INO
9.209
-0.642
-6.5127%
ISCO
2.05
0.00
0.00%
ISIS
57.56
0.00
0.00%
LGND
112.11
-3
-2.6061%
LPTN
2.172
-0.188
-7.9534%
MBVX
0.553
-0.028
-4.7414%
MEIP
1.36
+0.02
+1.49%
MNOV
7.05
-0.06
-0.84%
MRTX
6.025
-0.435
-6.734%
MSTX
0.45
-0.01
-1.38%
NBIX
42.88
-1.71
-3.83%
NUVA
58.065
-0.795
-1.351%
ONCS
1.63
+0.03
+1.87%
ONVO
3.33
-0.12
-3.48%
OREX
0.458
-0.04
-7.9534%
OTIC
15.6
-0.65
-4.00%
QDEL
17.12
-0.74
-4.14%
RCPT
231.96
0.00
0.00%
RGLS
5.305
-0.435
-7.578%
RMD
60.65
-3.43
-5.35%
SCIE
0.005
0.00
-5.5556%
SPHS
1.845
-0.045
-2.381%
SRNE
5.64
-0.24
-4.08%
TROV
4.46
-0.34
-7.0813%
VICL
4.46
-0.14
-3.04%
VOLC
18
0.00
0.00%
ZGNX
8.06
-0.35
-4.16%
ACAD
31.54
-1.96
-5.85%
AEMD
5.81
-0.33
-5.37%
APRI
0.419
-0.051
-10.851%
ARNA
1.81
-0.1
-5.24%
ATEC
0.31
+0.03
+9.62%
CNAT
1.967
-0.163
-7.6338%
CRXM
0.17
+0.02
+11.96%
CYTX
2.01
+0.01
+0.50%
DXCM
77.67
+0.08
+0.10%
GNMK
8.36
-0.61
-6.80%
HALO
8.56
-0.63
-6.86%
ILMN
138.86
-7.73
-5.2731%
INNV
0.23
+0.01
+2.61%
INO
9.209
-0.642
-6.5127%
ISCO
2.05
0.00
0.00%
ISIS
57.56
0.00
0.00%
LGND
112.11
-3
-2.6061%
LPTN
2.172
-0.188
-7.9534%
MBVX
0.553
-0.028
-4.7414%
MEIP
1.36
+0.02
+1.49%
MNOV
7.05
-0.06
-0.84%
MRTX
6.025
-0.435
-6.734%
MSTX
0.45
-0.01
-1.38%
NBIX
42.88
-1.71
-3.83%
NUVA
58.065
-0.795
-1.351%
ONCS
1.63
+0.03
+1.87%
ONVO
3.33
-0.12
-3.48%
OREX
0.458
-0.04
-7.9534%
OTIC
15.6
-0.65
-4.00%
QDEL
17.12
-0.74
-4.14%
RCPT
231.96
0.00
0.00%
RGLS
5.305
-0.435
-7.578%
RMD
60.65
-3.43
-5.35%
SCIE
0.005
0.00
-5.5556%
SPHS
1.845
-0.045
-2.381%
SRNE
5.64
-0.24
-4.08%
TROV
4.46
-0.34
-7.0813%
VICL
4.46
-0.14
-3.04%
VOLC
18
0.00
0.00%
ZGNX
8.06
-0.35
-4.16%
Home » Archive by Category

Syndication

Rosa & Co. and MathWorks Host Joint Webinar Discussion on How MATLAB and SimBiology Facilitate Quantitative Systems Pharmacology (QSP) Modeling and Analysis to Support Drug Development

June 22, 2016 – 5:35 am

SAN CARLOS, Calif., June 22, 2016 /PRNewswire/ — Rosa & Co. LLC, the leading commercial drug development advisory firm with expertise in QSP/PhysioPD™, today announced their participation in a joint webinar on July 13th, 2016 at 10:00 am and 2:00pm EDT with MathWorks, a developer of mathematical computing software and maker of MATLAB and SimBiology. QSP/PhysioPD approaches aim to predict the safety and therapeutic impact of a drug by quantifying the dynamics of its interactions with underlying pathophysiology in order to guide and support drug development.  This webinar will use a rheumatoid arthritis (RA) PhysioPD™ Research Platform developed by Rosa & Co to illustrate the utility of key features of MATLAB and SimBiology in exploring pharmaceutical research questions.

Logo – http://photos.prnewswire.com/prnh/20160621/381835LOGO  

Who:
Christina Friedrich, PhD, Chief Engineer, Rosa & Co.
Fulden Buyukozturk, PhD, Technical Evangelist, MathWorks Inc.

What:
Webinar: MATLAB and SimBiology facilitate QSP modeling and analysis to support drug development

When:
Wednesday, July 13th, 2016; 7:00 a.m. and 11:00 a.m. PT | 10:00 a.m. and 2:00 p.m. ET
Registration is required, though there is no charge to join.

Where:
Register here

About Rosa
Rosa supports clients with their critical decisions – from preclinical through clinical development – by creating and using customized PhysioPD™ Research Platforms that connect mechanisms to outcomes.  PhysioPD Platforms are Quantitative Systems Pharmacology models used to simulate normal and disease physiology, drug action, patient variability, and trial outcomes. Rosa’s clients are involved in Platform creation, testing, and biological simulation research. Clients retain the Platform as a program asset to support decisions and future research. Rosa’s staff has unparalleled professional experience applying biological modeling and simulation research to accelerate drug development and has over 13 years of client engagements in virtually all therapeutic areas. Rosa is unique in its breadth and depth of disease area experience, including metabolic diseases, immuno-oncology, oncology, cardiovascular, inflammation, immune dysfunction, central nervous system disorders, dermatology, rare disease, and antibacterial/antiviral biology. For more information, visit http://www.rosaandco.com/news.html.

About MathWorks
MathWorks is the leading developer of mathematical computing software. MATLAB, the language of technical computing, is a programming environment for algorithm development, data analysis, visualization, and numeric computation. Simulink is a graphical environment for simulation and Model-Based Design for multidomain dynamic and embedded systems. Engineers and scientists worldwide rely on these product families to accelerate the pace of discovery, innovation, and development in automotive, aerospace, electronics, financial services, biotech-pharmaceutical, and other industries. MATLAB and Simulink are also fundamental teaching and research tools in the world’s universities and learning institutions. Founded in 1984, MathWorks employs more than 3500 people in 15 countries, with headquarters in Natick, Massachusetts, USA. For additional information, visit mathworks.com.               

Rosa and the Rosa logo are registered trademarks of Rosa & Co. LLC.

MATLAB and Simulink are registered trademarks of The MathWorks, Inc. See mathworks.com/trademarks for a list of additional trademarks. Other product or brand names may be trademarks or registered trademarks of their respective holders.

Media Contact:
Stephanie Sherman
Email
425-591-5738

SOURCE Rosa & Co.

Radicle Accelerator Fund Launches to Nurture AgTech Innovation

June 22, 2016 – 4:30 am

Radicle, a new accelerator fund focused on agricultural ventures, is launching today with plans to seed and nurture the next generation of agtech companies addressing global farming problems. The new…

[[Click headline to continue reading.]]

Mesa Biotech Appoints Leading Experts to Inaugural Scientific Advisory Board

June 22, 2016 – 3:00 am

SAN DIEGO, June 22, 2016 /PRNewswire/ — Mesa Biotech Inc., a privately-held, molecular diagnostic company that has developed a testing platform designed specifically for point-of-care (POC) infectious disease diagnosis, today announced the formation of their scientific advisory board (SAB). Approved by the executive leadership team and board of directors, the SAB is chartered to advise on the development and commercialization of Mesa Biotech’s infectious disease assay platform. Led by Dr. Steve Young, this world-class team brings Mesa Biotech more than 120 years of combined experience in infectious diseases and molecular diagnostics.

“We are thrilled to have such a talented and experienced scientific advisory board providing critical expertise to the Mesa Biotech team,” said Hong Cai, co-founder and CEO. “The background and experience of our advisory board is going to be invaluable as we commercialize our current technology for the rapid testing of influenza A/B, as well as to help us successfully reach our goal of bringing transformative diagnostics to the point of care.”  

The inaugural members of Mesa Biotech scientific advisory board include:

  • Dr. Steve Young, director of research and clinical trials at TriCore Reference Laboratory, will chair the SAB. Dr. Young has completed over 100 FDA in vitro diagnostic device trials/market evaluations. He is also chairman, virology standards of the American Board of Medical Microbiology and holds a Ph.D. from the University of New Mexico.
  • Dr. Angela Caliendo is professor and vice-chair of medicine and vice-president of university medicine at the Alpert Medical School of Brown University. She brings extensive virology and molecular diagnostics experience to the SAB. Currently she chairs the microbiology medical devices panel at FDA and the Diagnostics Task Force for the Infectious Diseases Society of America (ISDA). Dr. Caliendo obtained her M.D. and Ph.D. in biochemistry from Case Western University.  
  • Dr. Jeanne A. Jordan is a professor, George Washington University and director of GWU’s International Institute for Public Health Laboratory Management. She has extensive clinical microbiology, laboratory medicine and virology expertise. Dr. Jordan is the chair of the Infectious Disease Division of the Association for Molecular Pathology and serves on the editorial board of the Journal of Clinical Virology. Dr. Jordan obtained her Ph.D. from the University of Pittsburgh.
  • Dr. James Nichols is a professor of pathology, microbiology, and immunology and medical director, clinical chemistry for the Vanderbilt University School of Medicine. He is Board certified in clinical and toxicological chemistry and has extensive evidence-based medicine, information management, lab automation, POC testing and toxicology experience. He also served as a member on CDC’s clinical laboratory improvement advisory committee. Dr. Nichols holds a Ph.D. in biochemistry from the University of Illinois.
  • Dr. Stephen Day is an experienced IVD consultant. He is a member of the Expert Panel on Molecular Methods for the Clinical Laboratory Standards Institute and has extensive experience in virology and molecular diagnostics. He is on the Professional Relations Committee of the Association for Molecular Pathology and has also held other elected positions within that organization. Dr. Day received his Ph.D. in microbiology/immunology/molecular biology from the University of South Alabama.
  • Dr. Chris Myers is a virologist and biosurveillance department head for the Naval Health Research Center. His team evaluates diagnostics for infectious disease targets and biowarfare/biothreat agents in clinics and operational settings and is responsible for respiratory and enteric disease surveillance in military populations. Dr. Myers received his Ph.D. from the University of Texas. 

About Mesa Biotech Inc.

Mesa Biotech is an emerging molecular diagnostic company, bringing the superior diagnostic performance of nucleic acid amplification to the point-of-care (POC). Mesa Biotech’s diagnostic system consists of a portable, palm-sized dock and a disposable, assay-specific test cassette. This patented system will allow healthcare professionals to obtain actionable, laboratory-quality results at the POC in 30 minutes or less with greater sensitivity and specificity than many current infectious disease rapid immunodiagnostic tests. Mesa’s technology development has been funded to date by a series of grants and private equity investments totaling approximately $30 million. The company is preparing for Series A funding in 2016 and expects to obtain FDA approval for its first product, an influenza assay and dock, in 2017. For more information visit http://www.mesabiotech.com.

 

SOURCE Mesa Biotech Inc.

SENIOR RESEARCH ASSOCIATE – PRE-CLINICAL DRUG DISCOVERY – Sorrento Therapeutics, Inc. – San Diego, CA

June 21, 2016 – 11:53 pm

Earn a competitive salary that allows you to focus your attention on your passion for science. If you’re a quick learner, enjoy working in the biotech industry,…
From DeviceSpace.com – 22 Jun 2016 06:53:04 GMT
– View all San Diego jobs

SENIOR RESEARCH ASSOCIATE – IN VIVO – Sorrento Therapeutics, Inc. – San Diego, CA

June 21, 2016 – 11:52 pm

In cellular biology, molecular biology, genetics, or pharmacology (or a related discipline) and 5 or more years of industry experience in the area of in-vivo…
From DeviceSpace.com – 22 Jun 2016 06:52:59 GMT
– View all San Die…

Hematology Oncology Consultant (Lymphoma) – San Diego/Hawaii – Celgene Corporation – San Diego, CA

June 21, 2016 – 9:23 pm

Description Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a
From Celgene Corporation – 22 Jun 2016 04:23:10 GMT
– View all San Die…

Senior Scientist, Enzymology – Celgene Corporation – San Diego, CA

June 21, 2016 – 9:22 pm

In Biochemistry with at least 6 years of relevant work experience, biotech or pharmaceutical experience, preferred….
From Celgene Corporation – 22 Jun 2016 04:22:49 GMT
– View all San Diego jobs

Senior Scientist in Cancer Immunology – BioDuro – San Diego, CA

June 21, 2016 – 5:51 pm

PhD in immunology, cell and molecular biology, biotechnology, biochemistry, genetics or any other relevant areas with applied research experience in the fields…
From DeviceSpace.com – 22 Jun 2016 00:51:39 GMT
– View all San D…

Scientist-Research Associate in Cancer Immunology – BioDuro – San Diego, CA

June 21, 2016 – 5:51 pm

PhD/MS/BS in immunology, cell and molecular biology, biotechnology, biochemistry, genetics or any other relevant areas with applied research experience in the…
From DeviceSpace.com – 22 Jun 2016 00:51:39 GMT
– View all San Di…

Hematology Oncology Consultant (Lymphoma) – Celgene – San Diego, CA

June 21, 2016 – 4:45 pm

Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to
From Celgene – 21 Jun 2016 23:45:44 GMT
– View all San Diego jobs